In those with childhood-onset GHD, the GH-IGF-I axis should be reevaluated in patients during the transition, except in those with multiple pituitary hormone deficiencies due to hypothalamic tumours, previous high dose radiotherapy (>30 Gy), or hypothalamic–pituitary surgery (84, 85). Here, GH1 is linked to hypopituitarism.